Home › Funds › Intesa Sanpaolo S.p.A. › ABBV
Intesa Sanpaolo S.p.A. position in ABBV
ABBVIE INC · Health Care
Intesa Sanpaolo S.p.A. reported holding 160,787 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$42.1M, representing 1.44% of its reported portfolio and ranking #15 among its reported holdings. Intesa Sanpaolo S.p.A. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Intesa Sanpaolo S.p.A.'s ABBV position evolved
Intesa Sanpaolo S.p.A. first disclosed a stake in ABBV in Q4 2025 at 80,944 shares (US$18.6M). The position peaked in Q3 2026 at 160,787 shares, worth US$42.1M. Across 4 filings, Intesa Sanpaolo S.p.A. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 160,787 shares valued at US$42.1M — an increase of 36,520 shares quarter over quarter.. Notable position changes include a 48% increase in Q2 2026 (shares rose 5% over the following quarter), a 29% increase in Q3 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 80.94K | $18.60M | New |
| Q1 2026 | 84.19K | $18.31M | Add |
| Q2 2026 | 124.27K | $31.27M | Add |
| Q3 2026 | 160.79K | $42.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABBV and 13F data
ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 148.97M sh · $38.97B · Q3 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.68M sh · $30.26B · Q3 2026
- STATE STREET CORP 82.82M sh · $21.66B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 49.00M sh · $12.82B · Q3 2026
- Geode Capital Management 47.50M sh · $12.40B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.40M sh · $10.04B · Q3 2026
- Capital Research Global Investors 31.12M sh · $8.14B · Q3 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Bank of America Corp 26.39M sh · $6.90B · Q3 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
More on Intesa Sanpaolo S.p.A.
FAQ
How long has Intesa Sanpaolo S.p.A. held ABBV?
Intesa Sanpaolo S.p.A. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Intesa Sanpaolo S.p.A.'s current position in ABBV?
As of Q3 2026, Intesa Sanpaolo S.p.A. holds 160.79K shares of ABBV (ABBVIE INC), valued at $42.06M, representing 1.44% of its reported portfolio and ranking #15.
Has Intesa Sanpaolo S.p.A. been buying or selling ABBV?
In the latest 13F filing (Q3 2026), Intesa Sanpaolo S.p.A. increased its position in ABBV. The position peaked in Q3 2026 at 160.79K shares.
Which other funds hold ABBV?
Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.